At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 50 enrolled
Drug / intervention
Ketamine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Randomized, Double-Blind, Controlled Trial Evaluating the Efficacy of Ketamine for Improvement in Postoperative Pain Control After Spinal Fusion for Idiopathic Scoliosis
In Brief
A Phase 4 clinical trial evaluating Ketamine and Placebo for Idiopathic Scoliosis and Post-operative Pain. Completed, enrolled 50 participants across 1 site.
Detailed Summary
This study hypothesizes that the addition of a low-dose ketamine infusion to usual post-operative pain management will improve pain control as evidenced by an improvement in post-operative pain scores for patients undergoing spinal fusion for idiopathic scoliosis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIdiopathic Scoliosis, Post-operative Pain
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2013
First PostedJan 2016
Primary CompletionDec 2017
TodayJul 2026
First PostedJan 11, 2016
Enrollment StartMay 1, 2013
Primary CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 10.5 years ago
Interventions
Ketaminedrug
Placeboother